Daily Pharmacy News

Get your free subscription started now. Just enter your email address below.

PNN JournalWatch — 10.23.23

Journal of Allergy and Clinical Immunology: Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes

Journal of Allergy and Clinical Immunology: Viral Infections and Chronic Rhinosinusitis

Lancet: Overall Survival With Sacituzumab Govitecan in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (TROPiCS-02): A Randomised, Open-Label, Multicentre, Phase 3 Trial

Lancet: Pegcetacoplan for the Treatment Of Geographic Atrophy Secondary To Age-Related Macular Degeneration (OAKS and DERBY): Two Multicentre, Randomised, Double-Masked, Sham-Controlled, Phase 3 Trials

Lancet: Efficacy and Safety of Avacincaptad Pegol in Patients With Geographic Atrophy (GATHER2): 12-Month Results From a Randomised, Double-Masked, Phase 3 Trial

Health Affairs: Mitigating Racial and Ethnic Bias and Advancing Health Equity in Clinical Algorithms: A Scoping Review

Health Affairs: Racial and Ethnic Disparities in Buprenorphine Receipt Among Medicare Beneficiaries, 2015–19

Source: Lancet, Health Affairs, Journal of Allergy and Clinical Immunology, JAMA Neurology